Bontempo Ohly Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.97M Sell
12,841
-74
-0.6% -$27.4K 2.11% 10
2026
Q1
$3.78M Buy
+12,915
New +$4.24M 1.71% 21

Other funds holding ELV

Bontempo Ohly Capital Management's ELV Position: Q2 2026 in Review

Bontempo Ohly Capital Management reduced its Elevance Health (ELV) stake by 0.57% in Q2 2026, selling an estimated $27.4K and leaving 12,841 shares worth $4.97M. The position accounts for 2.11% of the portfolio, ranked #10.

Bontempo Ohly Capital Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bontempo Ohly Capital Management held 12,841 shares of Elevance Health worth $4.97M as of Q2 2026.
  • Bontempo Ohly Capital Management sold 74 Elevance Health shares in Q2 2026, an estimated $27.4K.
  • Elevance Health made up 2.11% of Bontempo Ohly Capital Management's portfolio in Q2 2026, its #10 holding.
  • Bontempo Ohly Capital Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bontempo Ohly Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.